April 2017 - Page 162 of 169 -

FDA Rejects Eli Lilly’s Blockbuster Contender Baricitinib

Apr 14, 2017 Jeremy Parkinson Finance 0

The FDA has rejected Eli Lilly’s (NYSE:LLY) blockbuster contender baricitinib, saying that the pharma giant will need to gather more data to determine the proper doses that should be used by patients before regulators can reconsider their decision. Written by John Carroll (ENDpts.com) The kickback marks a stunning setback for…CEO Dave Ricks, who owes investors […]

Pharma Stock Roundup: Merck Gets CRL For Label Expansion Effort, Roche Cancer Drug Tops

Apr 14, 2017 Jeremy Parkinson Finance 0

It was a relatively slow week with key highlights including a complete response letter (CRL) for Merck’s (MRK – Free Report) label expansion efforts for its diabetes drugs and positive data on Roche’s (RHHBY – Free Report) lung cancer treatment. Recap of the Week’s Most Important Stories Roche Cancer Drug Tops Pfizer Drug in Study: Roche’s cancer drug, Alecensa, once […]

Good Quality ETFs And Stocks For An Edgy Market

Apr 14, 2017 Jeremy Parkinson Finance 0

Wall Street will be on holiday for Good Friday, but investors will be on the lookout for a bunch of good and timely bets as soon as the market reopens. This is even truer given the buoyancy in the market since the beginning of the year has rested a bit lately. Geopolitical tensions are back […]

KBW Bank Index Extended Correction

Apr 14, 2017 Jeremy Parkinson Finance 0

The KBW Bank Index is an economic index consisting of the stocks of 24 banking companies delivering a direct exposure to the banking sector and offering a targeted view to a unique corner of the U.S. financials sector. The top banks of the index are among the biggest financial institutions in the world and three of […]

Brexit Briefing: Now It’s All About A Hard Brexit Or A Soft One

Apr 14, 2017 Jeremy Parkinson Finance 0

Talking Points: As we wait for the Brexit negotiations to begin, it’s crucial to decide whether the two sides will reach an agreement or the UK will leave the EU without a deal. That could mean the difference between GBP/USD at 1.10 or with the pair at 1.50. Not long ago, the Reuters news agency asked FX […]

Retail Sales Decline For Second Straight Month As Real Earnings Stagnate

Apr 14, 2017 Jeremy Parkinson Finance 0

For the second month in a row, retail sales declined in March as ‘hard’ data fails to live up to ‘soft’ data’s hype. This is the biggest 2-month tumble in retail sales in over two years. The full breakdown shows the biggest declines in building materials and motor vehicles. This drop in sales should not be […]

Technical Levels For Majors And Crosses – Easter Edition

Apr 14, 2017 Jeremy Parkinson Finance 0

Trump triggered an uptick in foreign exchange volatility and currencies have moved. What technical levels should we look out for? The two videos below describe the levels to look out for in the upcoming week. Lines of support and resistance for the major pairs: EUR/USD, GBP/USD, USD/JPY, USD/CAD, AUD/USD, NZD/USD and USD/CHF. Lines of resistance […]

April 14 Daily Market Snap

Apr 14, 2017 Jeremy Parkinson Finance 0

Here’s what to watch out for today. 12:30 PM GMT US Core CPI At 12:30 PM GMT, the Core CPI numbers month over month for March come out of the United States, expected to be 0.2% at the time of announcement. A number higher than that will be good for the US dollar as it […]

Barrick Gold & Goldcorp Among 5 Companies With The Lowest Extraction Costs

Apr 14, 2017 Jeremy Parkinson Finance 0

Written by SmallCapPower.com Increasing geopolitical tensions have created upward momentum in the gold price of late. The 5 Canadian gold mining stocks—not only small caps—identified below have the lowest extraction costs (or cash costs) in the mining industry and, given their low production costs, will likely benefit most from a rising gold price environment. Cash costs refer […]

Easter Algos Dump Dollar After Dour Data Deluge

Apr 14, 2017 Jeremy Parkinson Finance 0

Earlier this morning the reflation narrative rolled over and died. That’s not just our dour assessment. Look around. The other folks who know what they’re talking about said exactly the same thing we did. Namely, that when it comes to the global reflation meme, the following is “bigly” bad… As a reminder, this comes on the […]